Seventh Annual Biotech Showcase™ to be held in San Francisco January 12–14, 2015 — Record number of Life Science Investor meetings expected
The seventh annual Biotech Showcase™ investor conference will be held January 12–14, 2015 in San Francisco, CA at Parc 55 Wyndham San Francisco – Union Square. The event brings executive-level delegates representing top public and private investment firms with the goal to meet management teams of biotechnology and life science companies, including therapeutic companies, specialty pharma, platform and molecular diagnostic companies.
“Biotech Showcase is a dedicated life science investor event taking place during one of the most important weeks of the year for healthcare investors. The event continues to grow because it puts investors directly in contact with emerging and innovative new biotech companies,” said Sara Jane Demy, CEO of Demy-Colton Life Science Advisors. “Investors and finance companies count on Biotech Showcase to kick off their investment strategies for the rest of the year.”
“The unique draw of Biotech Showcase is the caliber and diverse array of established investors and pharmaceutical executives who come to meet face-to-face with private and public biotechnology and life sciences companies,” said Anna Chrisman, Group Managing Director, EBD Group. “It has built a reputation among investors as having both high strategic value and a high level of opportunities.”
A pre-event BioMentorz Workshop entitled “The tactics of closing funding deals” will be held on Sunday, January 11. The workshop is designed for junior executives and is focused on strategic discussion and delivering results for securing funding at all levels. Pre-registration for the BioMentorz workshop is separate from the main Biotech Showcase registration.
On Monday, January 12, Biotech Showcase officially kicks off with morning workshops and the highly anticipated Alliance for Regenerative Medicine “State of the Industry Briefing,” followed by the opening Lunch Plenary entitled “Value creation: Private and Public investment strategies and stage gates for success.” The plenary will be moderated by Mike Griffith – Executive VP Commercial Division, inVentiv Health with panelists Stephen Bloch – General Partner, Canaan Partners; Ross Hammerman – Managing Director, UBS Investment Bank; John V. Oyler – Founder and CEO, BeiGene; and Melinda Richter – Head of Janssen Labs, Janssen Research & Development, LLC.
The highlight of the event and the primary draw for investors and pharma attending are the public and private company presentations taking place over three days. The presentations are broadly categorized into stage of financing and company type/focus area.
Biotech Showcase is co-produced annually by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of providing high quality business support programs and services to the biotechnology industry.
Participants of Biotech Showcase include qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives as well as other industry professionals. The 2014 edition attracted more than 1,700 attendees and featured 242 corporate presentations as well as a compelling program that addressed topics on investment and financing, progress in disease areas and business development trends.
Biotech Showcase is powered by partneringONE®, the industry’s most advanced meeting system that enables delegates to efficiently identify and arrange meetings with potential investors.
Companies interested in requesting a presentation slot can apply online. Applications will be accepted on a rolling basis.
Register before November 21 and save USD 200.
About Biotech Showcase™ 2015:
Biotech Showcase™ is an investor conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
The 2014 edition showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. The 2014 event featured corporate presentations by 242 public and private biotechnology and life science companies, and drew 1,700 delegates who engaged in 3,695 one-to-one meetings.
Follow Biotech Showcase 2015 on Twitter: twitter.com/ebdgroup (hashtag: #BTS15)
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
● BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
● BioPharm America™, the fastest growing partnering event in North America
● Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
● BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
● ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
● Medtech Partnering Forum Japan, EBD Group’s partnering event for the innovative medical technology industry
● The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
+1 760 930 0500
About Demy-Colton Life Science Advisors
Demy-Colton Life Science Advisors is focused exclusively on facilitating the growth of the life science industry. Demy-Colton has developed a number of high-value added conferences to address the business and development needs of the biotechnology industry; it provides partnering services and it has helped launch a unique investor website and newsletter.
Demy-Colton’s conferences include:
● US-Japan Health Sciences Dialogue: the only US-based business development conference focused on issues that influence the growth of the Japanese and western biopharmaceutical industry.
● Life Sciences Summit: a translational science partnering meeting focused on oncology, neurology, infectious disease and regenerative medicine that brings together academic innovators, biopharma executives and funders.
● Biotech Showcase™: an investor conference featuring public and private biotechnology and life sciences companies, which takes place annually in San Francisco during the week of the largest healthcare investor conference. This event is co-produced with EBD Group.
Demy-Colton’s online partnering systems, Collaborate™ and CollaborateTeam™ support Demy-Colton’s events and facilitates investor and venture meetings for the pharma industry and partnering for other organizations.
Demy-Colton Life Science Advisors has also been involved in the launch and development of The Life Sciences Report, a unique investor newsletter where third party experts share their opinions on investment opportunities. To subscribe to this free newsletter, click here. To become a sponsor, please contact Sara Jane Demy at email@example.com.
For more information please visit www.demy-colton.com
Jason Rando, Exec. Vice President & COO
Tiberend Strategic Advisors, Inc.
# # #